ACADIA Pharmaceuticals Inc. (ACAD)

NMS – Real Time Price. Currency in USD

21.72

-0.08 (-0.37%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

1.07B

958M

726M

517M

Cost of goods sold

-100M

-97M

-46M

-10M

Gross Profit

972M

861M

681M

507M

Operating expenses (excl. COGS)

-867M

-777M

-754M

-731M

Operating Income

105M

84M

-73M

-224M

Non-operating income, total

34M

174M

22M

10M

Pretax income

139M

258M

-51M

-213M

Equity in earnings

Taxes

252M

-32M

-10M

-3M

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

391M

226M

-61M

-216M

ACADIA Pharmaceuticals Inc. (ACAD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ACADIA Pharmaceuticals Inc. (ACAD)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

ACADIA Pharmaceuticals Inc. (ACAD)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

ACADIA Pharmaceuticals Inc. (ACAD)

Income Statement (Annual)

Income Statement (Annual)